IDWeek 2014

Eravacycline Shows High Activity Against Gram-Negative Pathogens

By October 09, 2014

Eravacycline, a novel antibacterial agent, demonstrated high in vitro activity against Gram-negative pathogens, including multidrug-resistant isolates.